GATINEAU – The Competition Bureau announced that it has entered into a consent agreement with Isologic Innovative Radiopharmaceuticals Inc. (Isologic) to address competition concerns with its contracting practices in the radiopharmaceutical industry. A Bureau investigation found that Isologic’s contractual practices with certain customers contravened the abuse of dominance provisions of the Competition Act. These practices affected certain customers purchasing radiopharmaceuticals used …